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Background: Using microarray analysis, this study showed up-regulation of toll-like receptors 1, 2, 4, 7, 8, NF-κB,
TNF, p38-MAPK, and MHC molecules in human peripheral blood mononuclear cells following infection with
Plasmodium falciparum.
Methods: This analysis reports herein further studies based on time-course microarray analysis with focus on
malaria-induced host immune response.
Results: The results show that in early malaria, selected immune response-related genes were up-regulated
including α β and γ interferon-related genes, as well as genes of IL-15, CD36, chemokines (CXCL10, CCL2, S100A8/9,
CXCL9, and CXCL11), TRAIL and IgG Fc receptors. During acute febrile malaria, up-regulated genes included α β and
γ interferon-related genes, IL-8, IL-1b IL-10 downstream genes, TGFB1, oncostatin-M, chemokines, IgG Fc receptors,
ADCC signalling, complement-related genes, granzymes, NK cell killer/inhibitory receptors and Fas antigen. During
recovery, genes for NK receptorsand granzymes/perforin were up-regulated. When viewed in terms of immune
response type, malaria infection appeared to induce a mixed TH1 response, in which α and β interferon-driven
responses appear to predominate over the more classic IL-12 driven pathway. In addition, TH17 pathway also
appears to play a significant role in the immune response to P. falciparum. Gene markers of TH17 (neutrophil-related
genes, TGFB1 and IL-6 family (oncostatin-M)) and THαβ (IFN-γ and NK cytotoxicity and ADCC gene) immune
response were up-regulated. Initiation of THαβ immune response was associated with an IFN-αβ response, which
ultimately resulted in moderate-mild IFN-γ achieved via a pathway different from the more classic IL-12 TH1 pattern.
Conclusions: Based on these observations, this study speculates that in P. falciparum infection, THαβ/TH17 immune
response may predominate over ideal TH1 response.
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TH1 has been suggested to be the dominant and pro-
tective immune response against malaria both in rodents
and humans [1,2]. Yet the blood stage of Plasmodium
falciparum can serve to immunosuppress the host’s im-
mune response to the liver stage of the parasite [3]Correspondence: lukluk73_2006@yahoo.com.tw
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reproduction in any medium, provided the orDendritic cell maturation is inhibited by P. falciparum-
infected red blood cells (RBCs) [4]; monocyte maturation
is also suppressed by malaria pigments (haemozoin), and
low serum IL-12 was reported in severe malaria [5,6].
These observations suggest that the IL-12-driven TH1,
IFNγ-dominant response patterns seen following P. falcip-
arum infection may not be functioning optimally; thus,
against this background data, one may ask how the in-
fected host is capable of mounting an effective TH1 re-
sponse against the blood-borne stage of this parasite? Anis an open access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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immune response.
To gain a better understanding of host immune re-
sponse patterns associated with P. falciparum infection in
humans, this study carried out transcriptional profiling
using microarray analysis of peripheral blood mono-
nuclear cells (PBMCs) after P. falciparum infection. The
earlier analysis showed an up-regulation of gene expres-
sion for toll-like receptor signalling, NF-κB, TNF, IFN-γ,
IL-1β, p38 MAPK, MHC class I and II molecules [7]. This
study further analysed the data focusing on the specific
type or types of host immune response induced by infec-
tion. Results indicated an up-regulation of TGF-β and the
IL-6 family gene (oncostatin M), both of which induce
TH17 immune response. This study also observed an ele-
vation in the expression of interferon gamma, NK cell
cytotoxicity, antibody-dependent cell cytotoxicity (ADCC),
which are triggered by interferon alpha/beta (THαβ), in-
stead of IL-12 (TH1). These results suggest multiple im-
mune pathways may be activated following infection with
P. falciparum. For the purpose of this study have classified
these additional pathways as: THαβ and TH17 immune
response. The THαβ pathway is not generally recognized
within the immunology community as a distinct T cell
maturation pathway while the TH17 response pattern has
only recently been recognized [8]. However, THαβ re-
sponses in which α and β interferons drive a succession of
cellular process leading to mid-moderate IFN-γ produc-
tion and NK cell and ADCC activation have been de-
scribed in the host response to viruses but they have not
been shown to play an important role in the maturation of
the anti-malaria adaptive immune response.
To further clarify this point, traditionally TH1 leads to
immune response against intracellular bacteria and proto-
zoa, and THαβ against viral infections. Macrophage
activation is characteristic of traditional TH1 immune re-
sponse, while NK activation (natural cytotoxicity and
ADCC) is more characteristic of THαβ immune response.
In addition, TH17 immune response is typical immuno-
logical pathway against extracellular bacteria and fungi.
Pathogens may induce ineffective host immune re-
sponse for immune evasion. Thus, malaria infection ap-
pears to be somewhat unique in that it appears to elicit
a combined response reflective of both TH17 and




This study was approved by Johns Hopkins University
School of Public Health Institutional Research Board
and Cameroon Department of Health Institutional Re-
search Board. Written informed consent was obtained
from each individual of this study.Previous analysis
Subject recruitment, sample collection and preparation,
and RNA [ribonucleic acid] purification were described
previously in Ockenhouse et al. [7]. Briefly, two groups
of subjects were recruited for this study after Johns
Hopkins University Institutional Review Board and US
Army HSRRB ethical approvals were obtained. In the
study cohort, 22 subjects, 20–45 years of age, were re-
cruited from the Walter Reed Army Institute of Re-
search (WRAIR). Subjects agreed to receive mosquito
bites from laboratory-reared Anopheles stephensi in-
fected by P. falciparum (3D7 strain). Once parasitaemia
was detected in the subjects’ peripheral blood, the sub-
jects received treatment with chloroquine. Blood sam-
ples were drawn during the un-infected baseline period
(U) and again, when parasitaemia was found for the first
time (early malaria (E)).
In the other study cohort, 15 adults were recruited from
Cameroon. These subjects were 19–49 years of age with
acute P. falciparum infection. All suffered from typical re-
lapsing fever and blood smears showed parasitaemia. Pa-
tients were excluded if they actively suffered from other
infectious or inflammation diseases. These subjects re-
ceived at least one week of anti-malarial drug treatment
(Cotecxin). Blood drawing was performed during the
acute febrile infection period (A) and one month later dur-
ing the recovery period (R). During the recovery period,
physical examinations and blood smears were performed
to ensure that malaria symptoms were no longer present
and parasitaemia was no longer detectable.
In the first study cohort, PBMCs were separated from
whole blood samples by Ficoll-gradient at WRAIR. In
the second study cohort, blood was collected in CPT
[Cell Preparation Tube] tubes and PBMCs were iso-
lated after centrifuge. A RNA stabilizing reagent-RNA
later (Ambion, CA, USA) was added and samples were
shipped to the USA on dry ice. Total RNA was ex-
tracted from both sets of samples using Trizol. The
quality of sample RNA was estimated by spectrometry
(OD > 1.8) and gel electrophoresis.
Microarray preparation
Affymetrix U133A GeneChips (Affymetrix, Santa Clara,
CA, USA) were used in this study. The GeneChips
contain 22,283 probe-sets, including 14,500 known well-
characterized human genes and 18,400 transcripts. Be-
fore chip hybridization, a QIAGEN RNeasy clean-up kit
was used to purify total RNA. Processing of templates
for analysis on the Affymetrix U133A GeneChip was
performed in accordance with methods described in
the Affymetrix Technical Manual, Revision Three. Total
RNA from the blood samples were hybridized into the
arrays. Detailed cDNA preparation, in vitro transcrip-
tion, staining, and scanning of Affymetrix U133A
Hu Malaria Journal 2013, 12:392 Page 3 of 19
http://www.malariajournal.com/content/12/1/392GeneChips were described previously in Ockenhouse
et al. [7] paper.
Data analysis
This study used GeneSpring software and GeneSpring
default normalization to perform one-way ANOVA tests,
using un-infected samples as baseline. Significantly up-
regulated genes were selected if false discovery rate
(FDR) was < 0.05 and fold change was >1.5 × when com-
pared to un-infected baseline. These genes were placed
into three groups based on expression levels in different
stages of the infection. In addition, Pearson’s correlation
analysis and Rank correlation analysis were performed
to find the relationship between expression levels of
genes after malaria infection. Pathway analysis was per-
formed by using the Pathway Architect (Stratagene Inc,
CA, USA) software to identify the specific immuno-
logical pathways involved.
Microarray validation
In order to validate the study’s microarray results, sev-
eral assays were used including flow cytometry and com-
mercial kits for plasma protein expression. Peripheral
blood mononuclear cells analysis was done by a FACS-
can flow cytometer (Becton-Dickinson, Mountain View,
CA) using a panel of mouse anti-human monoclonal
antibodies such as ICAM1 antibody before and after
malaria challenge. Measuring the chemokine levels in-
cluding CXCL10, CXCL9, and CCL2 in paired plasma
samples collected before and after malaria challenge
were done by using commercial kits (R&D systems,
Minneapolis, MN). These validation assays were de-
scribed in the previous Ockenhouse et al. [7] paper.
Microarray accession numbers
The Affymetrix data sets can be accessed at Gene Ex-
pression Omnibus [www.ncbi.nlm.nih.gov/geo/] under
the accession number GSE5418.
Results
A total of 2,894 genes were differentially expressed out of
the 22,283 probe sets in Affymetrix U133A GeneChip
based on the criteria of data analysis. Gene expression pat-
terns were measured in individuals with pre-symptomatic,
experimental, early malarial infection and in subjects with
naturally acquired acute febrile malarial infection. A base-
line set of data derived from 22 uninfected healthy US
subjects was used for gene comparison in samples from
early malarial infection, acute febrile malarial infection
and recovery stage. This baseline dataset is considered ap-
propriate for comparisons between Cameroonian samples
and USA samples because of the difficult in collecting
baseline samples from Cameroonian subjects that have
had no prior exposure to malaria. As indicated previously,the study site in Cameroon is endemic for malaria so it is
difficult to find adults in the area that may not already
be in the prodromal phase of malaria. The correlation
of the average gene expression of baseline samples to
the average gene expression from 22 USA subjects and
from 15 Cameroonian adults exceeded 97%, indicating
comparability of gene expression between datasets col-
lected and processed at the WRAIR for US volunteers
and at the Johns Hopkins Bloomberg School of Public
Health for Cameroonian subjects.
TH1 immune response-related gene up-regulation during
malaria
After P. falciparum infection, many immune response-
related genes of the TH1 immunological pathway were
up-regulated (Table 1). Although interferon alpha/beta
was not detected in this study, the major transcription
factor of interferon alpha/beta synthesis, IRF7, was up-
regulated after malaria. Many interferon alpha/beta in-
ducible genes were up-regulated during the early stage
of malaria including: tryptophenyl-tRNA (IFI53), inter-
feron alpha inducible protein 27 (IFI27), interferon-
induced protein 44 (IFI44), interferon-stimulated protein
15KD (G1P2), interferon regulatory factor 1 (IRF1), 2′-
5′-oligoadenylate synthetase 3 (OAS3), signal transducer
and activator of transcription 1 (STAT1), interferon
stimulated protein 35 (IFI35), Myxovirus resistance 1
(MX1), interferon-induced protein with tetratricopeptide
repeat 4 (IFIT4), interferon-induced protein with tetra-
tricopeptide repeat 1 (IFIT1), and interferon-induced
protein with tetratricopeptide repeat 2 (IFIT2). The ex-
pression levels of the above genes were greater than
two-fold in early malaria, as compared to un-infection
baseline. In acute febrile malaria, the expression levels of
most of the alpha/beta interferon genes tended to de-
cline and all returned to baseline levels of expression
during the recovery period (Table 1). Summary of all
four immunological pathways in malarial infection is
shown in Figure 1.
Interferon gamma and many interferon gamma-related
genes were also up-regulated after malaria. These obser-
vations are consistent with a model in which malaria in-
fection induces primarily a TH1 type immune response.
These up-regulated genes included: interferon gamma,
interferon inducible guanylate binding protein 1 (GBP1),
interferon inducible guanylate binding protein 2 (GBP2),
Janus kinase1 (JAK1), and transporter with antigen pro-
cessing 1 (TAP1). The expression levels of GBP1, GBP2,
and TAP1 ranged from 10.6- to 2.8-fold above baseline
during early stage of malaria, and the expression level of
GBP2 was greater than two-fold change during acute fe-
brile malaria. These interferon gamma inducible genes
all returned to baseline levels of expression during the
recovery periods of the disease. The up-regulation of a
Table 1 TH1 (primarily THαβ) immune response related gene up-regulation after malaria
U E E/U A A/U R R/U Gene TH1 Immune response
0.595 3.656 6.144 1.213 2.038 1.003 1.685 IFI53 IFNa/b
0.898 3.089 3.439 1.298 1.445 1.132 1.260 IFI27
0.825 2.375 2.878 1.077 1.305 0.928 1.124 IFI44
0.552 2.093 3.791 1.158 2.097 0.933 1.690 G1P2
0.51 2.07 4.058 1.031 2.021 0.947 1.856 IRF1
0.813 1.763 2.168 1.08 1.328 0.926 1.138 OAS3
0.579 1.829 3.158 1.058 1.827 0.977 1.687 STAT1
0.722 1.773 2.455 1.091 1.511 0.952 1.318 IFI35
0.881 1.586 1.800 1.069 1.213 0.898 1.019 OASL
0.672 1.498 2.229 1.046 1.556 0.954 1.419 MX1
0.662 1.532 2.314 1.26 1.903 1.097 1.657 IRF7
0.898 4.549 5.065 0.992 1.104 0.894 0.995 IFIT4
0.902 2.352 2.607 0.938 1.039 0.924 1.024 IFIT1
0.931 1.935 2.078 1.065 1.143 0.964 1.035 IFIT2
0.629 1.214 1.930 1.149 1.826 1.019 1.620 IFITM1
0.655 1.043 1.592 2.424 3.700 1.694 2.586 IFNG IFNg
0.587 6.22 10.596 1.099 1.872 0.823 1.402 GBP1
0.527 1.908 3.620 1.111 2.108 0.947 1.796 GBP2
0.755 1.273 1.686 1.182 1.565 0.951 1.259 IFNGR2
0.658 1.31 1.990 1.284 1.951 0.916 1.392 IFI30
0.781 1.333 1.706 1.322 1.692 1.123 1.437 JAK2
0.72 2.049 2.845 0.991 1.376 0.95 1.319 TAP1
0.781 1.371 1.755 1.057 1.353 1.067 1.366 JAK1
0.838 1.261 1.504 1.106 1.319 0.9 1.073 FcGR2B ADCC
0.863 1.199 1.389 1.925 2.230 1.075 1.245 FcAR
0.514 0.911 1.772 1.658 3.225 1.339 2.605 FcGR3B
0.708 1.208 1.706 1.132 1.598 0.896 1.265 FcGR2A
0.64 4.954 7.740 1.265 1.976 0.849 1.326 FcGR1A
0.751 1.285 1.711 1.412 1.880 1.035 1.378 C1QA
0.765 1.601 2.092 1.073 1.402 0.946 1.236 FcGR3A
0.597 1.237 2.072 1.658 2.777 1.339 2.242 FcER1G
0.953 0.658 0.690 1.298 1.362 1.502 1.576 CD3z
0.819 0.676 0.825 1.455 1.776 1.329 1.622 Fyn
0.656 1.029 1.568 1.219 1.858 1.035 1.577 DAP12
0.848 0.985 1.161 1.271 1.498 1.204 1.419 Syk
0.566 0.449 0.793 2.044 3.611 1.829 3.231 PI3K
0.748 1.108 1.481 1.152 1.540 1.03 1.377 Rac1
0.83 1.21 1.457 1.25 1.506 1.13 1.361 PAK1
0.823 0.807 0.980 1.464 1.778 1.191 1.447 MAP2K1
0.721 0.872 1.209 1.516 2.102 1.375 1.907 MAP2K2
0.644 0.81 1.257 1.547 2.402 1.382 2.145 Arf6
0.881 0.642 0.728 2.723 3.090 2.931 3.326 KLRC3 NK cell
0.829 0.868 1.047 1.26 1.519 1.492 1.799 NKEFB
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Table 1 TH1 (primarily THαβ) immune response related gene up-regulation after malaria (Continued)
0.927 0.848 0.914 1.442 1.555 1.432 1.544 KIR2DL3
0.857 0.694 0.809 2.199 2.565 2.1 2.450 KIR3DL2
0.77 3.235 4.201 0.835 1.084 0.798 1.036 TNFSF10
0.653 1.242 1.901 1.152 1.764 1 1.531 Fas
0.693 0.991 1.430 1.144 1.650 1.084 1.564 MICB
0.901 0.772 0.856 1.439 1.597 1.31 1.453 ETS1
0.704 0.899 1.276 1.596 2.267 1.379 1.958 CEBPg
0.757 1.145 1.512 1.119 1.478 1.02 1.347 MEF
0.638 0.765 1.199 1.674 2.623 1.458 2.285 ID2
0.71 1.397 1.967 1.092 1.538 0.884 1.245 IL15
0.908 0.738 0.812 1.521 1.675 1.626 1.790 GZMM
0.768 0.962 1.252 1.568 2.041 1.199 1.561 CD58
0.548 1.223 2.231 1.491 2.720 0.963 1.757 CCR1 TH1 Chemokine
0.381 0.974 2.556 2.085 5.472 1.713 4.496 CCL3
0.689 0.735 1.066 3.206 4.653 2.65 3.846 CCL4
0.986 5.194 5.267 1.045 1.059 0.956 0.969 CXCL10
1.029 1.576 1.531 0.835 0.811 0.83 0.806 CXCL9
0.824 1.265 1.535 0.924 1.121 0.808 0.980 CXCL11
0.863 0.641 0.742 1.495 1.732 1.557 1.804 GZMK CD8 T cell
0.795 0.651 0.818 1.98 2.490 1.739 2.187 GZMB
0.881 0.638 0.724 1.236 1.402 1.522 1.727 GZMA
0.829 0.765 0.922 1.432 1.727 1.385 1.670 RUNX3
0.656 1.07 1.631 1.308 1.993 1.106 1.685 Rel
0.925 0.812 0.877 1.497 1.618 1.593 1.722 CD3g
0.871 0.892 1.024 2.021 2.320 1.719 1.973 CDC42
0.749 0.692 0.923 1.885 2.516 1.524 2.034 Kras
0.78 1.159 1.485 1.209 1.55 1.094 1.402 ICOS
0.784 0.915 1.167 1.497 1.909 1.486 1.895 CD28
0.77 1.007 1.307 1.224 1.589 1.038 1.348 Bcl10
0.816 0.87 1.066 1.557 1.908 1.45 1.776 MALT1
Bold means greater than 2-fold change.
Italic means 1.5-2-fold change.
Plane means no change.
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course was also consistent with a TH1 model of anti-
malaria immune response. Up-regulated TH1 related
chemokine genes included: CXCL10, CCL3, CCL3 and
CCR1. The expression levels of CXCL10 (5.3-fold) was
highest during the early phase of malaria, while CCR3
and CCL4 were higher during febrile and recovery stages
of the disease (Table 1).
There were many ADCC and NK cell-related genes
up-regulated after malaria. ADCC-related genes in-
cluded: Fc receptors (Fc alpha receptor, Fc gamma recep-
tor 3B, Fc gamma receptor 1A, and Fc gamma receptor
3A), and ADCC signalling genes (CD3z, Fyn, DAP12,
Syk, PI3K, Rac1, PAK1, MAP2K1, MAP2K2, and Arf6).NK cell-related genes included NK cell receptor-related
genes (KLRC3and KIR3DL2), TNF superfamily ligand 10
(TRAIL), NK cell-related transcription factors (CEBP-
gamma,), interleukin 15, and NK cell-restricted granzyme
M. Interleukin 15 can enhance NK cell differentiation and
proliferation. ADCC is mainly mediated by NK cells, but it
can also be mediated by macrophages. Fc receptor and
ADCC signalling gene up-regulation is consistent with the
ADCC machinery being turned on after P. falciparum in-
fection. Among the above genes, gene expression levels
were greater than two-fold change (range two- to seven-
fold; see Table 1) in early malaria including: Fc gamma
receptor 1A, Fc gamma receptor 3A, Fc epsilon receptor
1G, and TRAIL. Gene expression levels were greater than
Figure 1 Summary of gene expression of four immunities of malaria. Summary of gene expression of the four immunological pathways
during the early malaria, acute febrile malaria, and recovery period compared to un-infection baseline. Red means gene expression with greater
than two-fold up-regulation. Yellow means gene expression with 1.5-2-fold up-regulation. Green means gene expression was not changed.
Square shape means genes which activate the cell, and ellipse shape means genes which suppress the cell. Although interferon alpha/beta was
not detected, (IRF7) means that this up-regulated gene regulates the transcription of interferon alpha/beta.
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alpha receptor, Fc gamma receptor 3B, Fc epsilon receptor
1G, PI3K, MAP2K2, Arf6, KLRC3, KIR3DL2, and CEBP
gamma (range two- to four-fold). Gene expression levels
were greater than two-fold change in the recovery period,
including: Fc gamma receptor 3B, Fc epsilon receptor 1G,
PI3K, Arf6, KLRC3, and KIR3DL2 range two- to three-
fold). Although ADCC signalling genes were not greater
than two-fold, they were higher than 1.5-fold change after
malarial infection. CTL-related genes (CD8 T cells in
Table 1) were only moderately up-regulated during mal-
aria. Among these genes, granzyme B, CDC42, and Kras
exhibited ≥ two-fold change during acute febrile malaria.
Granzyme B and Kras were ≥ two-fold change in the re-
covery period.
Although macrophage/monocyte activation is trad-
itionally considered to be a strong marker for classic
TH1 type immune response, this study surprisinglyfound that express levels of most macrophage activation
genes were relatively unchanged or slightly suppressed
after P. falciparum infection (Table 2). These data sup-
port the hypothesis that there may be two pathways
involved in the induction of TH1 types of immune re-
sponses: a THαβ interferon driven path and IL-12 driven
path (see Discussion). Most macrophage activation and
proliferation-related genes were unchanged (Table 2).
IL-12 is clearly the major cytokine needed to initiate a
strong classic TH1 type immune response, and IL-12 ex-
pression levels remain unchanged over the course of this
study (Table 2). This observation suggests that the in-
duction of a TH1-type anti-malarial immune response
may be driven by cytokines other than IL-12. Like IL-12,
other traditional TH1 cytokine: IL-3, M-CSF, and GM-
CSF can also cause macrophage proliferation but these
genes are also not up-regulated in response to infection
with P. falciparum (Table 2). In contrast, many macrophage
Table 2 TH1 (primary TH12) immune response unchanged after malaria
0.755 1.273 1.686 1.182 1.565 0.951 1.259 IFNGR2 Macrophage
1.02 0.91 0.892 1.16 1.137 1.13 1.107 CD40L Activation
0.804 1.271 1.580 1.132 1.407 1.098 1.365 TNFalpha
0.97 1.04 1.072 1.01 1.041 1.03 1.061 TNFbeta
0.733 1.263 1.723 1.293 1.763 0.864 1.178 TLR2
0.744 1.125 1.512 1.385 1.861 0.991 1.331 TLR4
0.739 1.051 1.422 1.408 1.905 1.044 1.412 TLR8
0.99 1.04 1.050 1.03 1.040 1 1.010 IL12A
1.02 1.04 1.019 0.96 0.941 0.95 0.931 IL12B
1.13 1.08 0.955 0.96 0.849 0.94 0.831 IL12RB1
1.04 1.16 1.115 1.02 0.980 0.97 0.932 IL12RB2
1.04 0.78 0.75 1.22 1.173 1.27 1.221 STAT4
1.03 1.08 1.048 1.02 0.990 1.01 0.980 iNOS
1.054 1 0.948 1 0.948 1.04 0.986 ASS
1 1.27 1.27 0.94 0.94 0.96 0.96 MMP9
0.87 0.98 1.126 1.19 1.367 1.12 1.287 TRAF6
0.98 1.03 1.051 0.99 1.010 1 1.020 TRANCE
1.05 1.06 1.009 0.94 0.895 0.94 0.895 RANK
0.99 1.039 1.049 0.97 0.979 0.99 1 ERM
1.07 1.08 1.009 0.93 0.869 0.92 0.859 M-CSF Macrophage
1.02 1.03 1.009 0.97 0.950 0.97 0.950 GM-CSF Proliferation
1.11 1.03 0.927 0.94 0.846 0.89 0.801 IL-3
0.92 1.04 1.130 1.13 1.228 1.04 1.130 RUNX1
0.86 0.89 1.034 0.85 0.988 0.84 0.976 Myb
1.21 1.25 1.033 0.81 0.669 0.87 0.719 Myc
1 1.24 1.24 1 1 0.95 0.95 CEBPalpha
1.04 1.04 1 1 0.961 1.03 0.990 HOXB7
1.06 1.17 1.103 0.95 0.896 0.97 0.915 GATA1
1.07 1.06 0.990 0.95 0.887 0.98 0.915 GATA2
1.12 1.19 1.062 0.82 0.732 0.86 0.767 Tal1
0.358 0.952 2.659 2.495 6.969 1.351 3.773 MafB
0.841 0.809 0.961 1.401 1.665 1.295 1.539 TGFBR2 Macrophage
0.85 1.355 1.594 1.024 1.204 0.727 0.855 CD36 Inhibition
0.706 0.972 1.376 1.307 1.851 1.209 1.712 CD47
0.943 0.783 0.830 1.521 1.612 1.097 1.163 CD163
0.522 0.781 1.496 1.776 3.402 1.556 2.980 JunB
0.51 2.07 4.058 1.031 2.021 0.947 1.856 IRF1
0.73 0.95 1.301 2.62 3.589 1.81 2.479 HMOX1
0.83 1.24 1.493 1.27 1.530 0.97 1.168 SIRPalpha
0.7 1.319 1.884 1.48 2.114 1.02 1.457 PU.1
Bold means greater than 2-fold change.
Italic means 1.5-2-fold change.
Plane means no change.
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cluding haem oxygenase 1 (HMOX1), JunB, and IRF1.
JunB, PU.1 and IRF1 suppress macrophage proliferation. Asindicated above, a macrophage differentiation inducer,
MafB, is up-regulated after malaria. Its antagonists, JunB
and PU.1, were also up-regulated, so the effect of MafB
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cytes to differentiate into dendritic cells instead of macro-
phages. Although macrophages can also express Fc
receptor genes, this study thinks these Fc receptor expres-
sion after malaria should mainly occur in NK cells. The Fc
receptor signalling pathway (ADCC signalling pathway) in
NK cell was all up-regulated (Table 1). Also, DAP12 up-
regulation can suppress Fc receptor signalling in macro-
phages, so it is less likely that these up-regulated Fc recep-
tors belong to macrophages. Although IL-10 itself was not
up-regulated, many IL-10 downstream genes were up-
regulated as shown in Figure 1 of the previous analysis
results [7]. IL-10 can activate NK cells and de-activateTable 3 TH17 related gene up-regulation after malaria
U E E/U A A/U R
0.767 0.775 1.010 1.275 1.662 1.
0.343 0.779 2.271 2.922 8.518 1.
0.805 1.265 1.571 2.276 2.827 1.
0.804 1.271 1.580 1.132 1.407 1.
0.653 1.019 1.560 1.346 2.061 1.
0.841 0.809 0.961 1.401 1.665 1.
0.795 0.907 1.140 1.849 2.325 1.
0.77 1.333 1.731 1.04 1.350 0.
0.764 0.894 1.170 2.98 3.900 1.
0.459 0.991 2.159 1.694 3.690 1.
0.903 1.552 1.718 0.899 0.995 0.
0.707 1.568 2.217 1.049 1.483 0.
0.667 0.97 1.454 2.827 4.238 1.
0.923 1.027 1.112 2.027 2.196 1.
0.745 1.4 1.879 1.182 1.586 0.
0.708 1.26 1.779 1.183 1.670 0.
0.722 1.948 2.698 1.155 1.599 0.
0.725 0.911 1.256 1.167 1.609 1.
0.954 2.945 3.087 0.939 0.984 0.
0.827 1.471 1.778 1.116 1.349 0.
0.742 1.047 1.411 1.202 1.619 1.
0.709 1.382 1.949 1.16 1.636 0.
0.918 1.131 1.232 1.619 1.763 1.
0.723 1.08 1.493 2.135 2.952 1.
0.635 1.087 1.711 2.079 3.274 1.
0.623 0.908 1.457 2.628 4.218 1.
0.552 0.881 1.596 2.297 4.161 1.
0.751 1.285 1.711 1.412 1.880 1.
0.67 0.914 1.364 1.349 2.013 1.
0.761 1.093 1.436 1.418 1.863 1.
Bold means greater than 2-fold change.
Italic means 1.5-2-fold change.
Plane means no change.macrophages. HMOX1 is the major downstream effector
molecule to mediate IL-10 inhibition of macrophages.
HMOX1 was up-regulated after malaria. HMOX1 gener-
ates CO molecule to mediate anti-inflammatory effects in
macrophages, which is opposite to nitric oxide synthetase
(iNOS), which generates NO molecule to cause inflamma-
tory effects. Argininesuccinate synthetase (ASS) is the rate-
limiting enzyme to synthesize arginine, the substrate of
iNOS. iNOS is the central mediator representing macro-
phage classical activation, and unchanged ASS and iNOS
express levels support the notion that macrophages are not
being activated after malaria infection. In the study, macro-
phages were inhibited rather than activated after malaria.R/U Gene TH17Immune response






























Table 4 TH2 related gene unchanged after malaria
U E E/U A A/U R R/U Gene TH2Immune response
1.09 1.06 0.972 0.97 0.889 1.02 0.935 IL4 IL4 CD4 Tcell
1.07 1.08 1.009 0.97 0.906 1 0.934 IL4R
1.02 1.08 1.058 0.99 0.970 0.97 0.950 IL5
1.06 1 0.943 0.98 0.924 0.99 0.933 IL5R
1.08 1.1 1.018 0.95 0.879 0.92 0.851 IL9
1.08 1.08 1 0.99 0.916 0.95 0.879 IL9R
0.94 0.99 1.053 1.15 1.223 1.09 1.159 IL10
0.93 0.85 0.913 1.08 1.161 1.17 1.258 IL10RA
1.09 1.05 0.963 0.95 0.871 0.92 0.844 IL13
0.98 1.14 1.163 1.23 1.255 0.99 1.010 IL13RA1
1.13 1.01 0.893 1.01 0.893 1.01 0.893 IL13RA2
1.1 1.13 1.027 0.91 0.827 0.96 0.872 CCR3
1.08 0.96 0.888 0.98 0.907 1.01 0.935 CCR4
1.11 1.2 1.081 0.86 0.774 0.95 0.855 CCR8
1.08 1.12 1.037 0.89 0.824 0.94 0.870 CCL17
0.99 1.1 1.111 0.91 0.919 0.95 0.959 CCL22
1.09 1.04 0.954 0.92 0.844 0.93 0.853 CRTH2
1.05 0.94 0.895 1.08 1.028 0.98 0.933 CD30
0.92 0.98 1.065 1.13 1.228 1.17 1.271 OX40
1.32 1.31 0.992 0.93 0.704 0.89 0.674 OX40L
1.01 0.88 0.871 1.01 1 0.99 0.980 STAT6
1 0.92 0.92 1.18 1.18 1.16 1.16 GATA3
0.98 1 1.020 0.96 0.979 1 1.020 NFATc
0.92 0.91 0.989 1.27 1.380 1.31 1.423 Gfi-1
0.96 1.09 1.135 1.1 1.145 1.07 1.114 SPHK1
1.05 1.02 0.971 0.97 0.923 1 0.952 SH2D1A
1.12 1.08 0.964 0.87 0.776 0.85 0.758 ST2L
1.11 1.06 0.954 0.94 0.846 0.98 0.882 A3AR Mast cell
1.1 1.13 1.027 0.91 0.827 0.96 0.872 CCR3
1.03 1.22 1.184 0.89 0.864 0.99 0.961 FCER2
1.14 0.63 0.552 1.17 1.026 1.72 1.508 FCER1A
1.09 1.13 1.036 0.93 0.853 1.01 0.926 LTC4S
0.95 0.96 1.010 1.11 1.168 1.05 1.105 MGST2
0.89 0.93 1.044 1.19 1.337 1.13 1.269 MGST3
0.92 0.92 1 0.84 0.913 0.85 0.923 CysLTR1
1.07 1.04 0.971 0.94 0.878 0.94 0.878 CysLTR2
1.02 1.08 1.058 0.99 0.970 0.97 0.950 IL5 Eosinophil
1.11 1.01 0.909 0.97 0.873 1.02 0.918 Eotaxin1
1.18 1.17 0.991 0.88 0.745 0.89 0.754 Eotaxin2
Italic means 1.5-2-fold change.
Plane means no change.
Underline means down-regulation.
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http://www.malariajournal.com/content/12/1/392In summary, many elements of TH1 immune response
were up-regulated following infection with P. falciparum,
including: interferon alpha/beta inducible genes, interferongamma inducible genes, NK cell-related genes (NK cell
cytotoxicity), ADCC-related genes, TH1 chemokines, and
CD8 T cell-related genes. However, macrophages appear to
Figure 2 Gene-to-gene correlation. This figure is to compare
STAT1 and STAT4 gene correlation in acute stage of malarial
infection. These twelve samples are from patients are Cameroon
acute malaria patients. There is negative correlation between STAT1
and STAT4, Pearson’s correlation coefficient (r) and its P value (p)
were calculated for the graph.
Table 5 Correlation between Fc receptor/complement
receptor and STAT1/STAT4 in acute febrile malaria
Gene STAT1 STAT4
FCER1G 0.9 (0.001) −0.71 (0.01)
FCGR1A 0.88 (0.001) −0.74 (0.01)
FCGR2A 0.79 (0.01) −0.79 (0.01)
FCGR2B 0.74 (0.01) −0.77 (0.01)
Fas 0.71 (0.01) −0.64 (0.05)
C3AR 0.86 (0.001) −0.73 (0.01)
DAF 0.64 (0.05) −0.66 (0.02)
C1QA 0.71 (0.01) −0.64 (0.05)
Properdin 0.82 (0.01) −0.68 (0.02)
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http://www.malariajournal.com/content/12/1/392become de-activated and do not appear to proliferate after
malarial infection.
TH17 immune response related gene up-regulation dur-
ing malaria
A number of genes associated with the newly described
TH17 immune response pathway were up-regulated
after infection with P. falciparum (Table 3). Of these
genes, IL-8 showed the greatest degree of up-regulation
over the entire course of the disease cycle (early, febrile
period and recovery periods), with expression levels
peaking during the febrile period of illness (8.5-fold in-
crease; Table 3). Other up-regulated genes included
other TH17-related cytokines, IL1β, TGFβ1, and oncos-
tatin M as well as TH17-related transcription factors,
CEBP delta, and CEBP gamma. In addition, selected
neutrophil-related genes were also up-regulated, includ-
ing: neutrophil attracting chemokines, S100A9, CXCL2,
and CXCL3, the neutrophil-related CD molecules,
ICAM1, the NADPH oxidases gene NCF1, and acute re-
action protein, PGE synthetase2. Many complement-
related genes were also up-regulated including C3A re-
ceptor1, C5 receptor1, delay-accelerating factor (DAF),
and Factor D.
TH2 immune response related genes unchanged during
malaria
Most TH2 immune response-related genes were remark-
ably unchanged over the course of the malaria disease
cycle (Table 4). An extensive analysis of TH2 cytokines
and chemokines, as well as Mast cell and eosinophil
genes revealed that gene expression level were essentially
unaffected by infection with P. falciparum, thus provid-
ing strong evidence that TH2-type immune response
was not significantly initiated during malaria in this
study. Expression levels for only a single gene involved
in Mast cell activation, Fc epsilon receptor 1A surface
receptor, was modified during the malaria disease cycle.
This gene was down-regulated during early malaria and
mildly up-regulated during recovery period.
Gene-to-gene relationship
This study performed Pearson’s correlation to analyse
gene-to-gene relationship after malaria infection and
found a number of relationships in the study subjects
that were consistent with observations by other investi-
gators in previous studies. This study observed a strong
negative Pearson’s correlation between the expression
levels of STAT1 and STAT4 in early malaria infection
and acute febrile malaria (Figure 2). There are positive
Pearson’s correlations between the expression level of
STAT1 and Fc receptors (ADCC-related genes), but
negative correlations between STAT4 and Fc receptors.
These observations suggested STAT1 up-regulated Fcreceptors. There is negative correlation between STAT1
and STAT4. Although some previous studies found that
STAT4, IL-12R, and Fc receptors are co-expressed,
STAT4 is not correlated or even negatively correlated
with these up-regulated Fc receptors in malarial infec-
tion. Fc receptors suppressed STAT4 expression or
STAT4 suppressed Fc receptors (Table 5). Rank correl-
ation has also been done, but there were no significant
results. Rank correlation is stricter than Pearson’s cor-
relation. If the data are normally distributed, Pearson’s
correlation analysis is more suitable than Rank correl-
ation analysis.
Immunological pathways
Pathway analysis was conducted to explore immuno-
logical genetic circuitry during malaria infection. This
study selected IL-4, IL-12, TGFB1/IL-6, IL-17, IFN-α/β
as the central gene markers to explore possible network-
ing among the 2,894 genes under analysis in this study.
This study was able to identify only a few up-regulated
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http://www.malariajournal.com/content/12/1/392genes in this cluster that centred on IL-4 (Figure 3) or
IL-12 (Figure 4). In contrast, gene networks centred on
TGFB1/IL6, IL-17 (Figure 5), or IFN-αβ (Figure 3) were
more dramatically altered during the malaria disease
cycle. These results further support a model for malaria
immune response in which IL-17/IFN-alpha/beta plays
a more central regulatory role than IL-4 and IL-12.
Figure 6 shows a sketch of the major pathways of hostFigure 3 IFNα/β and IL-4 centred pathway analysis. A IFN-αβ centred p
IFN-β as the central nodes. This study used software to select IFN-α or IFN-
were selected. Red entities mean proteins. Green entities mean small mole
family proteins. A—B means A binds to B to form a complex. A-→ B mea
induces B release. A—|B means A causes B’s degradation or inhibition. Litt
which regulates the conversion from A to B. B IL-4 centred pathway analy
This study used software to select IL-4 related genes from the gene list. Onimmune response that are felt to play a role in recovery
from malaria based on the observations made in this
study, as well as those made by other investigators in
previous research. The changes in their expression levels
during the early, acute and recovery stages of P. falcip-
arum infection are summarized in Figure 1. As shown in
Figures 1, 7, 8 and 9, the expression of genes related
to TH2 immune response were unchanged followingathway analysis. Network analysis was performed by using IFN-α and
β related genes from the gene list. 24 IFN-α or IFN-β related genes
cules including phospholipids and drugs. Hexon means groups of
ns A binds B’s promoter region to up-regulate B. A– + − > B means A
le square in the middle of the line means there is a third molecule
sis. Network analysis was performed by using IL-4 as the central nodes.
ly four IL-4 related genes were selected.
Figure 4 IL-12 centred network analysis. IL-12 centred pathway
analysis. Network analysis was performed by using IL-12 as the cen-
tral nodes. This study used software to select IL-12 related genes
from the gene list. Only four IL-12A/IL12B related genes
were selected.
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http://www.malariajournal.com/content/12/1/392malaria infection, with most changes occurring in genes
related to the TH17 and THαβ driven pathway of anti-
malaria immune response.
Validation by plasma and PBMC protein expression
In the previous analysis, this study found out the con-
cordance between transcription of genes and translation
of proteins in malarial infection. This study demon-
strated the similar up-regulation of ICAM1 level after
malarial infection between microarray RNA result and
surface protein expression detected by flow cytometry.
CXCL10, CXCL9, and CCL2 chemokine expressions are
up-regulated in this microarray finding. The above chemo-
kine proteins are also identified in plasma samples after
malarial infection. 4These results show that this microarray
analysis is validated as shown in Figure 4 in [7].
Discussion
Host immune response can be categorized into TH1,
TH2, and TH17 immune response pathways. TH1 im-
mune responses (Type 1 immune response) are IFN-γ
and IgG-mediated and they play an important role in
host responses to viruses and intracellular bacteria/protozoa. TH2 immune responses are IL-4 and IgE-
mediated immune response are important to host re-
sponses to helminths; TH17, initiated by TGF-β, IL-6
and IL-17 are important in host responses to extracellu-
lar bacterial pathogens [9-11]. In this research, these
data suggest that there should be a new immunological
pathway derived from the original TH1 immune re-
sponse: THαβ. THαβ is named after IFNα/β. In this
model, THαβ is triggered by interferon alpha/beta + IL-
10 and TH1 is triggered by interleukin 12. Based on
previous work by others, THαβ is important in host
immune response against virus infection; TH1 is import-
ant in host immune response against intracellular bac-
teria/protozoa. Different types of host immune response
have different effector cells. In TH2 immune response,
the effector cells are mast cells, eosinophils, basophils,
IgE/IgG4 secreting B cells, and IL-4 secreting CD4 T
cells. In TH17 immune response, the effector cells are
neutrophils, IgA/IgM/IgG2 secreting B cells, and IL-17
secreting CD4 T cells. In THαβ immune response, the
effector cells are NK cells, IgG1 secreting B cells, CTL,
and IL-10 (+++)/IFN-γ(+) secreting CD4 T cells. In TH1
immune response, the effector cells are macrophages,
IgG3 secreting B cells, CTL, and IFN-γ(+++) secreting
CD4 T cells. Similarly different types of host immune re-
sponse use different STAT proteins to initiate specific
immune reactions. IL-4 activates STAT6 in TH2 im-
mune response. TGF-β and IL-6 activates STAT3β in
TH17 immune response. Interferon alpha/beta and IL-
10 activates STAT1 and STAT3α in THαβ immune re-
sponse. IL-12 activates STAT4 in TH1 immune response
[12]. TGF-β and IL-2 activate STAT5 in regulatory T cell
(Treg) immune response. Based on these data, malaria
infection appears to induce a mixed TH17 and THαβ
immune response which best fits with a model in which
both pathways are activated during the onset and recov-
ery from malaria infection.
Others have shown that TGF-β with IL-6 can induce
TH17 immune response [10,11]. TH17 lymphocytes also
produce large amounts of IL-8, TNF-α and IL-1, which re-
cruit and activate neutrophils. Due to’ previous analysis,
toll-like receptor 1, 2, 4, 7, 8 are up-regulated after malar-
ial infection. TLR1/2/4 mainly induce anti-extracellular
bacteria TH17 immune response. TLR7/8 binding to sin-
gle strand RNA mainly induce anti-virus THαβ immune
response. In addition, this study found a lot of heat shock
proteins are up-regulated after malarial infection. Heat
shock proteins, mainly HSP60 or HSP70, can activate
TLR2/4 for inducing TH17 immune response. In this
study, TGF-β, IL-1, and IL-8 were strongly up-regulated in
acute malaria (Table 3). Although IL-17 was not up-
regulated, the IL-6-related cytokine family gene oncostatin
M, was up-regulated in acute malaria infection. oncos-
tatin M can up-regulate STAT3β, a key mediator in
Figure 5 TGF-β centred network analysis. TGF-β/oncostatin M centred pathway analysis. Network analysis was performed by using TGF-β/
oncostatin M as the central nodes. This study used software to select TGF-β/oncostatin M related genes from the gene list. 22 TGF-β/oncostatin
M related genes were selected. Red entities mean s proteins.
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http://www.malariajournal.com/content/12/1/392TH17 immune response [13]. Thus, it appears that
TH17 immune response can be induced in malaria in-
fection. Up-regulated TGF-β, IL-6, or TNF are associ-
ated with a higher frequency of malaria complications
and an overall poor malaria prognosis. A previous study
revealed that neutrophil-related genes were up-regulated
in children after acute P. falciparum malaria infection
[14]. They also reported up-regulation of IL-6 receptor,
C3AR1, C5R1, FPRL1, PBEF, and IL-1β, which are import-
ant components of TH17 immune response. Neutrophilia
has been observed in falciparum malaria, and elevated
white blood cell counts are associated with severe malaria
[15]. Gene network analysis of TGFB1/IL-6 or IL-17-
related gene expression after malaria infection also
suggested that malaria was TH17 dependent. Falciparum
malaria often causes complications such as acute renal
failure and acute respiratory distress syndrome (ARDS).
Neutrophil over-activation in TH17 immune response is
thought to play a major role in the pathogenesis of cere-
bral malaria, acute renal failure, and ARDS [16-18]. Thus,
malaria-induced TH17 immune response could be relatedto both malaria-induced cerebral malaria, acute renal fail-
ure and ARDS.
Evidence for dividing the more traditional TH1 im-
mune response pathway into two subtypes (THαβ and
TH1 immune response) comes primarily from both
mouse and human models of malaria immune response.
The major difference separating TH1 immune response
and THαβ immune response are the effector cells in-
volved. In the mouse model, interferon alpha/beta sup-
presses macrophage proliferation and neutrophiles and
NK cells play a more prominent role, in contrast, IL-12
enhances macrophage proliferation and human derived
macrophages can inhibit NK cells [19,20]. In addition,
interferon alpha/beta increases NK cell blastogenesis,
so alpha/beta interferon enhances NK cell proliferation
[21]. Thus, interferon alpha/beta and IL-12-mediated
immunological events can be distinguished by the dif-
ferent effector cells they enhance, NK cells or macro-
phages [22].
Mouse models of anti-malaria immune response indi-
cate that interferon gamma and TH1 immune response
Figure 6 Proposed model for the four types of host immune response. Green means unchanged and red means up-regulated genes after
malaria infection. TH2 immune response is induced by STAT6 activated by IL-4. THαβ immune response is induced by STAT1 & STAT3α activated
by IFN-αβ. TH1 immune response is induced by STAT4 activated by IL-12. TH17 immune response is induced by STAT3β activated by TGF-β/IL-6
to induce downstream PMN related genes and pro-inflammatory cytokines (TNFα, IL1, IL8). In THαβ immune response, IFN-α/β can suppress
STAT6. IFN-α/β also suppress iNOS and IL-12 via IL-10 dependent mechanism. Up-regulated STAT1 can suppress GATA3 and STAT4. STAT1 can
up-regulate IRF1, T-bet, IgG Fc receptors, Fas, C3a receptor. IRF1 induced TRAIL, T-bet induced NK cell killer receptors, and Fas can enhance NK cell
cytotoxicity. Up-regulated IgG Fc receptors can mediate ADCC. In T cell, T-bet can up-regulate IFN-γ. Up-regulated IFN-γ can activate STAT1 signal-
ling via IFN-γ receptor. However, the IFN-γ receptor is suppressed during lymphocyte maturation. Thus, THαβ immune response can be separated
from TH1 immune response.
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http://www.malariajournal.com/content/12/1/392play central roles in the developmental process [2]. Al-
though administration of IL-12 can provide 100% pro-
tection against malaria parasite challenge, IL-12 plays a
limited role in natural immune response against malaria
in mice [1]. Active immunosuppression is well docu-
mented during malaria infection in mice [3]. IL-12 ex-
pression is down-regulated in this model [23]. According
to an IRF1 knock-out study, mice can initiate TH1 im-
mune response by bypassing the need for IL-12 produc-
tion through the use of an alternate interferon alpha/
beta driven pathway [24]. Based on recent microarray
studies in malaria-infected mice, there is no evidence of
IL-12 up-regulation following infection. Instead, inter-
feron alpha/beta and its related genes were found to be
significantly up-regulated [25,26], thus providing further
evidence at the gene level that interferon alpha/beta can
substitute for IL-12 in the induction of malaria-specific
interferon gamma TH1 type immune response after in-
fection in rodents. However, the IFNαβ driven THαβ im-
mune response only can produce mid-to-moderate
IFNg, and IL-10, the main effector molecule in THαβ
immune response, antagonizes the effect of IFNg upon
macrophages. Because the ideal traditional TH1 immune
response cannot be triggered in natural malarial infec-
tion in human to clear out the protozoa, malaria para-
sites can cause severe illness in human.
In human, there is also a substantial amount of evi-
dence indicating that TH1 immune response can beinduced by two pathways driven by αβ interferon or IL-
12 [27,28]. Administration of IL-12 to human subjects
suppresses NK cell proliferation [29]. Macrophage acti-
vation serves to inhibit NK cell function, while NK cell
activation serves to inhibit macrophage proliferation
[19,30]. Given these observations, it is reasonable to
speculate that these two effector cells belong to different
immunological pathways. In the present study, this study
found that a number of genes involved in the NK cell
proliferation were up-regulated over the course of the
malaria disease cycle (Table 1). In addition, as in the
mouse model, genes associated with macrophage pro-
liferation were not up-regulated following infection
with P. falciparum. Increased NK cell populations have
also been reported previously in acute malaria infec-
tion [31,32], thus, it appears that the interferon alpha/
beta-NK cell pathway of THαβ immune response is
preferentially enhanced after P. falciparum infection,
while the IL-12 driven pathway appears unaffected.
Other THαβ-related cytokines also can cause NK cell
activation or proliferation including IL-10 and IL-15,
respectively [33].
In human malarial infection, it has been shown that
serum IL-12 levels are inversely correlated with malaria
parasitaemia [6]. The more severe the malaria is, the lower
IL-12 expression levels become. The uptake of malarial pig-
ment (haemozoin) can down-regulate IL-12 secretion in
human monocytes [5]. Malarial PGE2-like molecules can
Figure 7 Gene expression during early malarial infection, The meaning of colours is stated as Figure 1. This figure summarized the
expressed genes of the four immunological pathways in early malarial infection.
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http://www.malariajournal.com/content/12/1/392also down-regulate IL-12 secretion [34]. Up-regulation of
CD36 by malarial infection can inhibit dendritic cell matur-
ation with decreasing IL-12/IL-10 ratio [4]. Although hae-
mozoin, in certain studies, can activate TLR9, which is for
traditional TH1 immune response, TLR9 was not detected
in this study. In previous microarray analysis of human
malarial infection, interferon inducible genes were up-
regulated with unchanged IL-12 expression [14,35]. Other
important components of THαβ immune response in-
cluded up-regulation of HMOX1, FAS, BCL6, TNFRSF10A,
and MIP1α were noted in Griffiths’ research [14], which
studied the peripheral blood leukocytes from Kenyanchildren with acute falciparum malaria. In this microarray
study, this study ound up-regulation of interferon alpha/
beta, interferon gamma, NK cell activating receptors, Fas,
TRAIL, Fc gamma receptors, ADCC-related genes, IL-15,
granzymes, and TH1 related chemokines (IP10, CXCL9,
CXCL11, CCL3, CCL4, CCR1). These observations are, in
general, consistent with the development of THαβ immune
response characterized by NK cell activation induced by
alpha/beta interferon following P. falciparum infection.
Genes associated with TH1 immune response driven by
IL-12 and macrophage activation (iNOS up-regulation)
were unchanged after malarial infection. Gene coding for a
Figure 8 Gene expression during acute febrile malarial infection, The meaning of colours is stated as Figure 1. This figure summarized
the expressed genes of the four immunological pathways in acute febrile malarial infection.
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regulated, including TGFβ receptor, CD36, CD163-Haem
oxygenase1, and CD47-SIRPα. These molecules can actively
suppress macrophage activation. When given alone and
prior to malaria infection, IL-12 can provide 100% protec-
tion against experimental Plasmodium infection through
the activation of macrophages, which help to control the
liver stage of infection [1]. However, based on the data col-
lected during the course of the current study, it also
appears that infected individuals defend malaria through
an alternate THαβ immune response, involving alpha/beta
interferon and the activation of NK cells [36]. Interferongamma plays a central role in immune response against
malaria. However, the natural host immune response is
suboptimal because IFN-γ is not the main effector in THαβ
immune response. The major effector cells of THαβ im-
mune response are NK cells, and the major effector cells of
traditional TH1 immune response are macrophages.
Although IL-10, a strong macrophage de-activator, was
not up-regulated in this study, many downstream genes
of IL-10 were up-regulated including haem oxygenase 1,
and it suggests that IL-10 is actually up-regulated after
malaria infection. In an ideal situation, TH1 immune re-
sponse is basically immune response against intracellular
Figure 9 Gene expression during the recovery period. The meaning of colours is stated as Figure 6. This figure summarized the expressed
genes of the four immunological pathways in recovery period after malarial infection.
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http://www.malariajournal.com/content/12/1/392bacteria/protozoa; THαβ immune response is basically
immune response against viruses. Although, it appears
that macrophages may not be activated in natural im-
mune response against malaria, interferon gamma(+)
and IL-10(+++) secreting CD4 T cells, cytotoxic CD8
T cells, IgG secreting B cells, and NK cells are up-
regulated by interferon alpha/beta in malarial infection.
In a clinical study in Gabon, interferon-γ and IL-10 se-
creting CD4 T cells were increasing and correspondent
to the recovery of P. falciparum infection [37]. Pure TH1
interferon-γ producing T cells and pure TH2 IL-4 produ-
cing T cells were not changed during convalescenceafter malaria infection. Thus observation is consistent
with a model in which interferon-γ and IL-10 secreting
T cells play important roles in host immune response
against malaria.
Conclusions
It appears that the human immune response to P. falcip-
arum is characterized by a suboptimal THα/β and TH17
bias, which predominates over the more ideal and effect-
ive traditional TH1 responses driven by IL-12. Since
treatment for malarial infection faces some difficulty,
such as drug resistance, this study strongly encourage
Hu Malaria Journal 2013, 12:392 Page 18 of 19
http://www.malariajournal.com/content/12/1/392the use of IFNγ (FDA approval drug) or IL-12 for malar-
ial infection treatment to achieve the optimal host im-
mune response to kill the intracellular protozoa.
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